Ongoing large randomized clinical trials on complex percutaneous coronary interventions: intravascular imaging-guided trials
Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block - ScienceDirect
Comparative Analysis of Procedural Outcomes and Complications Between De Novo and Upgraded Cardiac Resynchronization Therapy
Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel
Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block - ScienceDirect
Heart failure: an update from the last years and a look at the near future - Riccardi - 2022 - ESC Heart Failure - Wiley Online Library
PDF) Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
Summary of evidence of RCTs of de novo CRT implantation compared with
CRT-600.05 Precise Assessments of Dissection Following Drug-Coated Balloon Treatment and Its Impact on Clinical Outcomes in De Novo Small Vessel Disease
Frontiers Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
Optimizing Foundational Therapies in Patients With HFrEF: How Do We Translate These Findings Into Clinical Care?
TCT-119 Procedural and Clinical Outcomes of IS-CTO and De Novo CTO PCIs
Frontiers Extra-Pulmonary Vein Triggers at de novo and the Repeat Atrial Fibrillation Catheter Ablation
Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction - ScienceDirect
The benefits of the earlier use of sacubitril/valsartan in de novo heart failure with reduced ejection fraction patients - Oh - 2022 - ESC Heart Failure - Wiley Online Library